Several years ago, our team showed that low doses of IGF-I were able to correct osteopenia associated to experimental cirrhosis [20], suggesting a role for IGF-I deficiency in the genesis of osteopenia and the possible therapeutic effect of IGF-I in this condition. This evidence concerns the gene IGF1 and hyperinsulinemic hypoglycemia, familial, 4.